About Index Trending news
Analyze
Top 50 Pricing
Eleven Biotherapeutics

Eleven Biotherapeutics

Work at Eleven Biotherapeutics? Add yourself to this profile

Eleven Biotherapeutics

Eleven Biotherapeutics is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$20,000,000
Venture capital (Series A)
$35,000,000
Employees

Team size

10+
Locations
HQ
Acquisition
Seeking Alpha , businesswire

Eleven Biotherapeutics acquires Viventia Bio in all-stock deal